FDA inspection
Ritsa Pharma Private Limited: FDA inspection ending Sep 29, 2023
FDA inspection 1221786 · No Action Indicated (NAI) · Medchal Malkajgiri, Hyderabad
Key facts
| Inspection ID | 1221786 |
|---|---|
| Firm | Ritsa Pharma Private Limited |
| FEI number | 3025926685 |
| Address | Neovantage Park, Bldg.1800, Survey No 101,101/2,340, 1800 Genome Valley Road |
| City | Medchal Malkajgiri, Hyderabad |
| Fiscal year | 2023 |
| Inspection end date | Sep 29, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data